Post-Discontinuation Treatments in IFCTGFPC-0701 MAPS Trial: Real-World Effectiveness of 2nd-Line (2L) Treatments for Mesothelioma

  • Etude concernée: MAPS
  • Auteurs / Authors: G. Zalcman, S. Brosseau, J. Mazieres, J. Margery, L. Greillier, C. Audigier-Valette, D. Moro-Sibilot, O. Molinier, R. Corre, I. Monnet, V. Gounant, F. Rivière, R. Gervais, H. Janicot, C. Locher, A. Langlais, J-J. Parienti, F. Morin, A. Scherpereel
  • Journal / Conference: WCLC
  • Année / Year: 2019
  • PMID: Oral abstract
  • Lien vers la publication: https://www.jto.org/article/S1556-0864(19)31215-8/fulltext